Drug
Puregon®
Puregon® is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph not_applicable
1
20%
Ph phase_2
1
20%
Ph phase_4
2
40%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
Terminated1
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 42 (50.0%)
N/A1 (25.0%)
Trials by Status
terminated120%
completed240%
recruiting120%
unknown120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingphase_4
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
NCT06175832
completedphase_2
Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)
NCT00702806
completed
Corifollitropin Alfa and Embryo Morphokinetics
NCT04142190
terminatednot_applicable
Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment
NCT01882166
unknownphase_4
Corifollitropin Alfa Versus Follitropin Beta in High Responders
NCT02471677
Clinical Trials (5)
Showing 5 of 5 trials
NCT06175832Phase 4
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
NCT00702806Phase 2
Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (P07015)
NCT04142190
Corifollitropin Alfa and Embryo Morphokinetics
NCT01882166Not Applicable
Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment
NCT02471677Phase 4
Corifollitropin Alfa Versus Follitropin Beta in High Responders
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5